The new funding was led by Balderton Capital and Future Positive Capital.
Launched in 2013 by Ida Tin and Hans Raffauf, Clue empowers women and people with cycles to make better choices for themselves around their menstrual, sexual and reproductive health and wellbeing, starting with personalised period tracking.
Since the beginning, Clue has been a trailblazer in combining science, research and data protection to provide a trusted service to its global user base. The platform now has users in over 190 countries around the world, accessing information that helps them manage their health by tracking their experience in 15 different languages through the free app. The Clue Plus paid subscription gives users access to premium features including symptom predictions, cycle analysis, Clue Pregnancy mode and curated content.
At Clue, we’re focused on empowering women and people with cycles with trustworthy information and empathetic tools to better understand their bodies, make good choices for themselves, self-manage and self-advocate. To deliver on this, and specifically as we prepare to launch Clue Birth Control, we’ve had to grow as an organization to work in an even more responsible and transparent way. We’re delighted to be welcoming new investors that believe in this mission and can support and advise us as we continue to develop new features that empower women and people with cycles across the world. 
